NATURE’S SUNSHINE PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 30.00K shares.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 64.00K shares, a 23.08% increase from fiscal 2019.
- NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 52.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2020-12-31 | 64.00K shares 10-K · filed 2021-03-10 | |
| 2019-12-31 | 52.00K shares 10-K · filed 2021-03-10 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | |
| 2018-03-31 | 30.00K shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |